医院高危药品管理模式的研究
|
摘要
目的:促进医疗机构合理使用高危药品,提高用药的准确性和安全性。方法:参考国内外高危药品的管理经验,从高危药品管理制度、药品目录、药品管理软件等方面,总结高危药品管理的先进方法。结果与结论:高危药品在临床使用过程中具有较高风险,应引起医疗机构和医生的高度重视。我国对于高危药品的标准化管理研究起步较晚,虽然部分医院实施了一些具体措施并取得了一定成效,但医疗机构仍应该在不同的技术层面和管理方式上加大对高危药品的标准化管理力度。
Objective: To promote the rational use of high risk drugs in medical institutions and to improve the accuracy and safety of medication. Methods: This paper summarized the advanced management methods of high risk drugs from the aspects of high risk management system, drug catalogue and drug management software according to the domestic and foreign experience in the management of high risk drugs. Results and Conclusion: Because there was high risk in the clinical application of high risk drugs, medical institutions and doctors should pay more attention to those drugs. Research on standardized management of high risk drugs in China started relatively late. Although some hospitals had implemented some specific management measures and achieved some results, medical institutions still need to enhance the standardization of management of high risk drug at different technical levels and by different management methods.
Objective: To promote the rational use of high risk drugs in medical institutions and to improve the accuracy and safety of medication. Methods: This paper summarized the advanced management methods of high risk drugs from the aspects of high risk management system, drug catalogue and drug management software according to the domestic and foreign experience in the management of high risk drugs. Results and Conclusion: Because there was high risk in the clinical application of high risk drugs, medical institutions and doctors should pay more attention to those drugs. Research on standardized management of high risk drugs in China started relatively late. Although some hospitals had implemented some specific management measures and achieved some results, medical institutions still need to enhance the standardization of management of high risk drug at different technical levels and by different management methods.
引文
[1]张幸国,饶跃峰,张国兵,等.医院高危药品管理制度的理论研究和实践[J].中国药房,2009,20(22):1690-1692.
[2]Walliser G,Grossberg R,Reed MD.Look-alike Medications:a Formula for Possible Morbidity and Mortality in the Long-term Care Facility[J].J Am Med Dir Assoc,2007,8(8):541-542.
[3]Patient Safety Alert.High-alert Medications and Patient Safety[J].Int J Qual Health Care,2001,3(4):339-340.
[4]Anonymous.Joint Commission IDs Five High-alert Meds[J].ED Manag,2000,12(2):21-22.
[5]Julie G,Peggy JW.High-alert Medications in the Periopera-tive Setting[J].J Peri Anesth Nurs,2007,22(6):435-436.
[6]候颖,叶欣,宋洪涛.医疗机构高危药品管理[J].中国医院药学杂志,2010,30(16):1399-1401.
[7]Golembiewski J,Wheeler PJ.High-alert Medicationsin the Perioperative Setting[J].J Perianesth Nurs,2007,22(6):435-437.
[8]Federico F.Preventing Harm from High-alert Medications[J].Jt Comm J Qual Patient Saf,2007,33(9):537-542.
[9]Paparella S.High Alert Medications:No Room for Errors[J].J Emerg Nurs,2003,30(4):348-350.
[10]Khoo AL,Teng M,Lim BP,et al.A Multicenter,Multidisciplinary,High-alert Medication Collaborative to Improve Patient Safety:the Singapore Experience[J].Jt Comm J Qual Patient Saf,2013,39(5):205-212.
[11]Cotrina Luque J,Guerrero Aznar MD,Alvarez Del Vayo Benito C,et al.An Pediatr(Barc)[J].Arch Gerontol Geriatr,2013,6(13):1695-4033.
[12]Winit-Watjana W,Sakulrat P,Kespichayawattana J.Criteria for High-risk Medication Use in Thai Older Patients[J].Arch Gerontol Geriatr.,2008,47(1):35-51.
[13]李大魁.常用处方药使用指南[M].北京:中国协和医科大学出版社,2000.
[14]陈永春,陈晓艳.SHEL模式在门诊药房高危药品管理中的应用[J].中国药物警戒,2013,10(1):57-58.
[15]吴若琪.高危药品管理的新策略[N].中国医药报,2012-05-16(0007).
[16]世光.高危药品与用药安全研讨会暨中国医药报刊协会用药安全信息专业委员会成立大会在京召开[J].中国药房,2013,24(4):351-351.
[17]吴红月.开展高危药品系统性研究刻不容缓[N].科技日报,2012-12-03(010).
[18]白毅.开展高危药品系统性研究迫在眉睫[N].中国医药报,2012-12-15(005).
[19]韩璐.高危药品管理在摸着石头过河[N].健康报,2013-05-28(002).
[20]张明生.病区高危药品的管理问题及思考[J].中国医药指南,2012,10(30):377-378.
[21]张婷,马丽萍,马罡,等.高危药品分级管理模式探讨[J].中国药房,2013,24(13):1183-1185.
[22]Kaushal R,Shojania KG,Bates DW.Effects of Computerized Physician Order Entry and Clinical Decision Support Systems on Medication Safety:A Systematic Review[J].Arch Intern Med,2003,163(12):1409-1416.
[23]张波,梅丹.医院高危药物管理和风险防范[J].中国药学杂志,2009,44(1):3-6.
[24]Bates DW,Teich JM,Le E J,et al.The Impact of Computerized Physician Order Entry on Medication Error Prevention[J].J Am Med Inform Assoc,1999,6(4):313-321.
[25]Hollister D,Messenger A.Implementation of Computerized Physician Order Entry at a Community Hospital[J].Conn Med,2011,75(4):227-233.
[26]崔杰,李秀敏,闫荟,等.“北京军区总医院高危药品管理系统”软件开发及应用[J].中国药房,2011,22(29):2706-2708.
[27]何忠芳,陈志雄,光奇,等.高危药品计算机辅助医嘱系统的设计和开发[J].中国现代应用药学,2012,29(11):1058-1060.
[28]孙世光,李秀敏,崔杰,等.医院高危药品管理模式研究[J].药学服务与研究,2010,10(4):256-259.
[29]许秀娟,万建伟.我院高危药品管理实践及体会[J].中国药业,2014,(14):5-7.
[30]李娟,魏安华,刘璇,等.医疗机构中高危药品用药安全管理实践[J].中国医院药学杂志,2013,33(9):735-743.
[31]张蕾,刘丹,佘继刚,等.基于医院信息系统的高危药品管理软件的设计与开发[J].药学与临床研究,2016,(1):94-96.
[2]Walliser G,Grossberg R,Reed MD.Look-alike Medications:a Formula for Possible Morbidity and Mortality in the Long-term Care Facility[J].J Am Med Dir Assoc,2007,8(8):541-542.
[3]Patient Safety Alert.High-alert Medications and Patient Safety[J].Int J Qual Health Care,2001,3(4):339-340.
[4]Anonymous.Joint Commission IDs Five High-alert Meds[J].ED Manag,2000,12(2):21-22.
[5]Julie G,Peggy JW.High-alert Medications in the Periopera-tive Setting[J].J Peri Anesth Nurs,2007,22(6):435-436.
[6]候颖,叶欣,宋洪涛.医疗机构高危药品管理[J].中国医院药学杂志,2010,30(16):1399-1401.
[7]Golembiewski J,Wheeler PJ.High-alert Medicationsin the Perioperative Setting[J].J Perianesth Nurs,2007,22(6):435-437.
[8]Federico F.Preventing Harm from High-alert Medications[J].Jt Comm J Qual Patient Saf,2007,33(9):537-542.
[9]Paparella S.High Alert Medications:No Room for Errors[J].J Emerg Nurs,2003,30(4):348-350.
[10]Khoo AL,Teng M,Lim BP,et al.A Multicenter,Multidisciplinary,High-alert Medication Collaborative to Improve Patient Safety:the Singapore Experience[J].Jt Comm J Qual Patient Saf,2013,39(5):205-212.
[11]Cotrina Luque J,Guerrero Aznar MD,Alvarez Del Vayo Benito C,et al.An Pediatr(Barc)[J].Arch Gerontol Geriatr,2013,6(13):1695-4033.
[12]Winit-Watjana W,Sakulrat P,Kespichayawattana J.Criteria for High-risk Medication Use in Thai Older Patients[J].Arch Gerontol Geriatr.,2008,47(1):35-51.
[13]李大魁.常用处方药使用指南[M].北京:中国协和医科大学出版社,2000.
[14]陈永春,陈晓艳.SHEL模式在门诊药房高危药品管理中的应用[J].中国药物警戒,2013,10(1):57-58.
[15]吴若琪.高危药品管理的新策略[N].中国医药报,2012-05-16(0007).
[16]世光.高危药品与用药安全研讨会暨中国医药报刊协会用药安全信息专业委员会成立大会在京召开[J].中国药房,2013,24(4):351-351.
[17]吴红月.开展高危药品系统性研究刻不容缓[N].科技日报,2012-12-03(010).
[18]白毅.开展高危药品系统性研究迫在眉睫[N].中国医药报,2012-12-15(005).
[19]韩璐.高危药品管理在摸着石头过河[N].健康报,2013-05-28(002).
[20]张明生.病区高危药品的管理问题及思考[J].中国医药指南,2012,10(30):377-378.
[21]张婷,马丽萍,马罡,等.高危药品分级管理模式探讨[J].中国药房,2013,24(13):1183-1185.
[22]Kaushal R,Shojania KG,Bates DW.Effects of Computerized Physician Order Entry and Clinical Decision Support Systems on Medication Safety:A Systematic Review[J].Arch Intern Med,2003,163(12):1409-1416.
[23]张波,梅丹.医院高危药物管理和风险防范[J].中国药学杂志,2009,44(1):3-6.
[24]Bates DW,Teich JM,Le E J,et al.The Impact of Computerized Physician Order Entry on Medication Error Prevention[J].J Am Med Inform Assoc,1999,6(4):313-321.
[25]Hollister D,Messenger A.Implementation of Computerized Physician Order Entry at a Community Hospital[J].Conn Med,2011,75(4):227-233.
[26]崔杰,李秀敏,闫荟,等.“北京军区总医院高危药品管理系统”软件开发及应用[J].中国药房,2011,22(29):2706-2708.
[27]何忠芳,陈志雄,光奇,等.高危药品计算机辅助医嘱系统的设计和开发[J].中国现代应用药学,2012,29(11):1058-1060.
[28]孙世光,李秀敏,崔杰,等.医院高危药品管理模式研究[J].药学服务与研究,2010,10(4):256-259.
[29]许秀娟,万建伟.我院高危药品管理实践及体会[J].中国药业,2014,(14):5-7.
[30]李娟,魏安华,刘璇,等.医疗机构中高危药品用药安全管理实践[J].中国医院药学杂志,2013,33(9):735-743.
[31]张蕾,刘丹,佘继刚,等.基于医院信息系统的高危药品管理软件的设计与开发[J].药学与临床研究,2016,(1):94-96.